Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

ABSTRACT: Thyroid cancer management is rapidly changing. The identification of actionable biomarkers through both germline and somatic testing are now an integral part of directing patient management. However, deficiencies and disparities within existing thyroid cancer biomarker test approaches are resulting in inconsistent application for patient care. An expert panel was convened to create consensus biomarker testing algorithms and recommendations on actionable biomarker testing for patients diagnosed with medullary thyroid cancer, non-anaplastic follicular cell-derived thyroid cancer, or anaplastic follicular cell-derived thyroid cancer who may benefit from targeted therapies. A review of international guidelines was performed to determine the current state, and a literature review was carried ou

SUBMITTER: Mete O 

PROVIDER: S-EPMC11659332 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature